BeOne Medicines Files 2025 Annual Report, Details GAAP Differences

BeOne Medicines Ltd. filed its 2025 Annual Report with the Science and Technology Innovation Board (STAR Market) of the Shanghai Stock Exchange on April 14, 2026. The report, prepared under PRC GAAP, includes additional financial information for the year ended December 31, 2025, such as gross profit margin, R&D expenses by product, and production, sales, and inventory data. The company also detailed key differences between PRC GAAP and U.S. GAAP, specifically regarding share-based compensation and leasing accounting treatments.